The National Institutes of Health (NIH) is offering a funding opportunity titled "Clinical Trial Readiness to Understand and Develop Solutions to Social, Ethical, Behavioral Implications and Barriers to Health Equity in ADRD (R01 - Clinical Trial Not Allowed)." This initiative aims to support research that establishes clinical trial readiness for community-driven interventions addressing health disparities in Alzheimer's Disease Related Dementias (ADRD), particularly among underserved populations. The focus is on understanding the social, ethical, and behavioral barriers that affect these communities, with an emphasis on developing inclusive research strategies and community engagement. The total funding available is $2.25 million for three awards, with a maximum budget of $500,000 per year over four years. Interested applicants must submit their proposals by October 4, 2024, and can direct inquiries to grantsinfo@nih.gov for further information.